Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (18)av-1451
2. (18f)1451
3. (18f)av-1451
4. (18f)flortaucipir
5. (18f)t807 Compound
6. (f-18)-av-1451
7. (f-18)t807
8. 7-(6-fluoropyridin-3-yl)-5h-pyrido(4,3-b)indole
9. Av-1451
10. Av1451
11. F-18-av-1451
12. Flortaucipir
13. Flortaucipir (18f)
14. Flortaucipir (f 18)
15. Flortaucipir (f-18)
16. T-807
17. T-807 F-18
18. T807 Compound
1. 1415379-56-4
2. T807
3. T-807
4. Flortaucipir
5. J09qs3z3wb
6. 5h-pyrido(4,3-b)indole, 7-(6-fluoro-3-pyridinyl)-
7. 7-(6-fluoropyridin-3-yl)-5h-pyrido(4,3-b)indole
8. Unii-j09qs3z3wb
9. 7-(6-fluoranylpyridin-3-yl)-5h-pyrido[4,3-b]indole
10. Flortaucipir (f-18)
11. Chembl3546271
12. Schembl14053964
13. Dtxsid701027894
14. Bcp24019
15. Av1451
16. Zinc148048492
17. Av-1451av-1451
18. Cs-6898
19. Db15033
20. Bs-15380
21. Hy-101184
22. Ft-0699855
23. C72630
24. A910886
25. 7-(6-fluoro-3-pyridinyl)-5h-pyrido[4,3-b]indole
26. Q27280989
27. T807(f18); Ly 3191748;7-(6-(fluoro-18f)pyridin-3-yl)-5h-pyrido[4,3-b]indole
| Molecular Weight | 263.27 g/mol |
|---|---|
| Molecular Formula | C16H10FN3 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 263.08587549 g/mol |
| Monoisotopic Mass | 263.08587549 g/mol |
| Topological Polar Surface Area | 41.6 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 351 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
Digital Content 
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A flortaucipir (F 18) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of flortaucipir (F 18), including repackagers and relabelers. The FDA regulates flortaucipir (F 18) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. flortaucipir (F 18) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A flortaucipir (F 18) supplier is an individual or a company that provides flortaucipir (F 18) active pharmaceutical ingredient (API) or flortaucipir (F 18) finished formulations upon request. The flortaucipir (F 18) suppliers may include flortaucipir (F 18) API manufacturers, exporters, distributors and traders.
flortaucipir (F 18) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of flortaucipir (F 18) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right flortaucipir (F 18) GMP manufacturer or flortaucipir (F 18) GMP API supplier for your needs.
A flortaucipir (F 18) CoA (Certificate of Analysis) is a formal document that attests to flortaucipir (F 18)'s compliance with flortaucipir (F 18) specifications and serves as a tool for batch-level quality control.
flortaucipir (F 18) CoA mostly includes findings from lab analyses of a specific batch. For each flortaucipir (F 18) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
flortaucipir (F 18) may be tested according to a variety of international standards, such as European Pharmacopoeia (flortaucipir (F 18) EP), flortaucipir (F 18) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (flortaucipir (F 18) USP).
LOOKING FOR A SUPPLIER?
